Molecules · 2016 · 43 citations · 35 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibacterial AgentsAntibacterial PharmacologyAntibiotic ResistanceLead Compound DesignStructure-activity Relationship AnalysisAntibacterial Drug DevelopmentAntibiotic DiscoveryBacillus SubtilisChemical Structure-activity RelationshipsCytotoxicity AssaysMinimum Inhibitory Concentration DeterminationNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
A series of new 2-phenyl-quinoline-4-carboxylic acid derivatives was synthesized starting from aniline, 2-nitrobenzaldehyde, pyruvic acid followed by Doebner reaction, amidation, reduction, acylation and amination. All of the newly-synthesized compounds were characterized by ¹H-NMR, (13)C-NMR and HRMS. The antibacterial activities of these compounds against Gram-negative (Escherichia coli, Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis), as well as one strain of methicillin-resistant Staphylococcus aureus (MRSA) bacteria were evaluated by the agar diffusion method (zone of inhibition) and a broth dilution method (minimum inhibitory concentration (MIC)), and their structure-activity relationships were obtained and discussed. The results revealed that some compounds displayed good antibacterial activity against Staphylococcus aureus, and Compounds 5a₄ and 5a₇ showed the best inhibition with an MIC value of 64 μg/mL against Staphylococcus aureus and with an MIC value of 128 μg/mL against Escherichia coli, respectively. The results of the MTT assay illustrated the low cytotoxicity of Compound 5a4.
35
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 465 citations · Full text
Beth A. Arthington‐Skaggs, Milwood Motley, David W. Warnock et al. · Journal of Clinical Microbiology · 2000 · 203 citations · Full text